Clinical trial
CLEAR Study: Clinical Experience Acquired With Raptiva Study
NCT00256139 · Merck KGaA, Darmstadt, Germany, Industry · Completed
Key facts
| NCT number | NCT00256139 |
|---|---|
| Title | CLEAR Study: Clinical Experience Acquired With Raptiva Study |
| Lead sponsor | Merck KGaA, Darmstadt, Germany, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Moderate to Severe Psoriasis |
| Intervention type | Drug |
| Interventions | Raptiva |
| Enrollment | 793 |
| Start date | Mar 1, 2003 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Nov 21, 2005 |
| Last update posted | Jan 16, 2017 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: